{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:01:21Z","timestamp":1790751681734,"version":"4.1.0"},"publisher-location":"Berlin, Heidelberg","reference-count":110,"publisher":"Springer Berlin Heidelberg","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/82_2026_361","type":"book-chapter","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:33:19Z","timestamp":1790749999000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dysregulated Resolution of Inflammation in Atherosclerosis: Mechanistic Insights and Therapeutic Opportunities"],"prefix":"10.1007","author":[{"given":"Manikandan","family":"Subramanian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"issue":"11","key":"361_CR1","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/s41569-024-01037-7","volume":"21","author":"SS Adkar","year":"2024","unstructured":"Adkar SS, Leeper NJ (2024) Efferocytosis in atherosclerosis. Nat Rev Cardiol 21(11):762\u2013779","journal-title":"Nat Rev Cardiol"},{"issue":"16","key":"361_CR2","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1161\/CIRCULATIONAHA.106.662080","volume":"115","author":"H Ait-Oufella","year":"2007","unstructured":"Ait-Oufella H et al (2007) Lactadherin deficiency leads to apoptotic cell accumulation and accelerated atherosclerosis in mice. Circulation 115(16):2168\u20132177","journal-title":"Circulation"},{"issue":"1","key":"361_CR3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/ni871","volume":"4","author":"HA Anderson","year":"2003","unstructured":"Anderson HA et al (2003) Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells. Nat Immunol 4(1):87\u201391","journal-title":"Nat Immunol"},{"issue":"24","key":"361_CR4","doi-asserted-by":"crossref","first-page":"e142883","DOI":"10.1172\/JCI142883","volume":"131","author":"H Arnardottir","year":"2021","unstructured":"Arnardottir H et al (2021) The resolvin D1 receptor GPR32 transduces inflammation resolution and atheroprotection. J Clin Invest 131(24):e142883","journal-title":"J Clin Invest"},{"issue":"7","key":"361_CR5","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.RES.0000264498.60702.0d","volume":"100","author":"M B\u00e4ck","year":"2007","unstructured":"B\u00e4ck M et al (2007) 5-Lipoxygenase-activating protein. Circ Res 100(7):946\u2013949","journal-title":"Circ Res"},{"issue":"7","key":"361_CR6","first-page":"389","volume":"16","author":"M B\u00e4ck","year":"2019","unstructured":"B\u00e4ck M et al (2019) Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities. Nat Rev Cardiol 16(7):389\u2013406","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"361_CR7","doi-asserted-by":"crossref","first-page":"8034","DOI":"10.1038\/s41467-024-52005-1","volume":"15","author":"S Bamezai","year":"2024","unstructured":"Bamezai S et al (2024) Pro-efferocytic nanotherapies reduce vascular inflammation without inducing anemia in a large animal model of atherosclerosis. Nat Commun 15(1):8034","journal-title":"Nat Commun"},{"key":"361_CR8","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115075","volume":"201","author":"M Bardin","year":"2022","unstructured":"Bardin M et al (2022) The resolvin D2 \u2013 GPR18 axis is expressed in human coronary atherosclerosis and transduces atheroprotection in apolipoprotein E deficient mice. Biochem Pharmacol 201:115075","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"361_CR9","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/CIRCRESAHA.115.306361","volume":"118","author":"MR Bennett","year":"2016","unstructured":"Bennett MR, Sinha S, Owens GK (2016) Vascular smooth muscle cells in atherosclerosis. Circ Res 118(4):692\u2013702","journal-title":"Circ Res"},{"issue":"1","key":"361_CR10","doi-asserted-by":"crossref","DOI":"10.1111\/imr.70095","volume":"337","author":"KA Boden","year":"2026","unstructured":"Boden KA et al (2026) Trained immunity and cardiovascular risk: an immunological perspective. Immunol Rev 337(1):e70095","journal-title":"Immunol Rev"},{"issue":"4","key":"361_CR11","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/ATVBAHA.124.321662","volume":"45","author":"DM Boucher","year":"2025","unstructured":"Boucher DM et al (2025) Age-related impairments in immune cell efferocytosis and autophagy hinder atherosclerosis regression. Arterioscler Thromb Vasc Biol 45(4):481\u2013495","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"361_CR12","doi-asserted-by":"crossref","DOI":"10.1111\/bcpt.70026","volume":"136","author":"AM Briones","year":"2025","unstructured":"Briones AM et al (2025) Role of inflammatory and proresolving mediators in endothelial dysfunction. Basic Clin Pharmacol Toxicol 136(5):e70026","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"10","key":"361_CR13","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.3390\/molecules29102233","volume":"29","author":"L Byrne","year":"2024","unstructured":"Byrne L, Guiry PJ (2024) Advances in the chemistry and biology of specialised pro-resolving mediators (SPMs). Molecules 29(10):2233","journal-title":"Molecules"},{"issue":"23","key":"361_CR14","doi-asserted-by":"crossref","first-page":"6526","DOI":"10.1073\/pnas.1524292113","volume":"113","author":"B Cai","year":"2016","unstructured":"Cai B et al (2016) MerTK cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammation. Proc Natl Acad Sci 113(23):6526\u20136531","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"361_CR15","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1172\/JCI90520","volume":"127","author":"B Cai","year":"2017","unstructured":"Cai B et al (2017) MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis. J Clin Invest 127(2):564\u2013568","journal-title":"J Clin Invest"},{"issue":"9","key":"361_CR16","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.15252\/emmm.201607492","volume":"9","author":"A Canfr\u00e1n-Duque","year":"2017","unstructured":"Canfr\u00e1n-Duque A et al (2017) Macrophage deficiency of miR-21 promotes apoptosis, plaque necrosis, and vascular inflammation during atherogenesis. EMBO Mol Med 9(9):1244\u20131262","journal-title":"EMBO Mol Med"},{"issue":"4","key":"361_CR17","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2011.03.018","volume":"34","author":"A Chaudhry","year":"2011","unstructured":"Chaudhry A et al (2011) Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 34(4):566\u2013578","journal-title":"Immunity"},{"issue":"7395","key":"361_CR18","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature11042","volume":"484","author":"N Chiang","year":"2012","unstructured":"Chiang N et al (2012) Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature 484(7395):524\u2013528","journal-title":"Nature"},{"issue":"1\u20132","key":"361_CR19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cell.2017.12.013","volume":"172","author":"A Christ","year":"2018","unstructured":"Christ A et al (2018) Western diet triggers NLRP3-dependent innate immune reprogramming. Cell 172(1\u20132):162\u2013175.e14","journal-title":"Cell"},{"issue":"1","key":"361_CR20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/mi.2017.36","volume":"11","author":"M Codagnone","year":"2018","unstructured":"Codagnone M et al (2018) Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection. Mucosal Immunol 11(1):35\u201349","journal-title":"Mucosal Immunol"},{"issue":"9","key":"361_CR21","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1172\/JCI97947","volume":"128","author":"MS Conte","year":"2018","unstructured":"Conte MS et al (2018) Pro-resolving lipid mediators in vascular disease. J Clin Invest 128(9):3727\u20133735","journal-title":"J Clin Invest"},{"issue":"3","key":"361_CR22","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.4049\/jimmunol.1300613","volume":"192","author":"A Das","year":"2014","unstructured":"Das A et al (2014) Engulfment of apoptotic cells by macrophages: a role of microRNA-21 in the resolution of wound inflammation. J Immunol 192(3):1120\u20131129","journal-title":"J Immunol"},{"issue":"6","key":"361_CR23","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41590-020-0646-0","volume":"21","author":"RPH De Maeyer","year":"2020","unstructured":"De Maeyer RPH et al (2020) Blocking elevated p38 MAPK restores efferocytosis and inflammatory resolution in the elderly. Nat Immunol 21(6):615\u2013625","journal-title":"Nat Immunol"},{"key":"361_CR24","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105699","volume":"170","author":"UK Dhawan","year":"2021","unstructured":"Dhawan UK, Singhal A, Subramanian M (2021a) Dead cell and debris clearance in the atherosclerotic plaque: mechanisms and therapeutic opportunities to promote inflammation resolution. Pharmacol Res 170:105699","journal-title":"Pharmacol Res"},{"issue":"10","key":"361_CR25","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1161\/ATVBAHA.120.316389","volume":"41","author":"UK Dhawan","year":"2021","unstructured":"Dhawan UK et al (2021b) Hypercholesterolemia impairs clearance of neutrophil extracellular traps and promotes inflammation and atherosclerotic plaque progression. Arterioscler Thromb Vasc Biol 41(10):2598\u20132615","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"361_CR26","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1161\/CIRCRESAHA.125.326353","volume":"137","author":"UK Dhawan","year":"2025","unstructured":"Dhawan UK et al (2025) Macrophage DNases limit neutrophil extracellular trap-mediated defective efferocytosis in atherosclerosis. Circ Res 137(10):1255\u20131275","journal-title":"Circ Res"},{"issue":"9","key":"361_CR27","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1161\/CIRCRESAHA.115.304164","volume":"115","author":"E Distel","year":"2014","unstructured":"Distel E et al (2014) miR33 inhibition overcomes deleterious effects of diabetes mellitus on atherosclerosis plaque regression in mice. Circ Res 115(9):759\u2013769","journal-title":"Circ Res"},{"issue":"1","key":"361_CR28","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1161\/CIRCRESAHA.121.319822","volume":"130","author":"AC Doran","year":"2022","unstructured":"Doran AC (2022) Inflammation resolution: implications for atherosclerosis. Circ Res 130(1):130\u2013148","journal-title":"Circ Res"},{"issue":"4","key":"361_CR29","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41577-019-0240-6","volume":"20","author":"AC Doran","year":"2020","unstructured":"Doran AC, Yurdagul A Jr, Tabas I (2020) Efferocytosis in health and disease. Nat Rev Immunol 20(4):254\u2013267","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"361_CR30","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1161\/ATVBAHA.120.315452","volume":"41","author":"C Drummer","year":"2021","unstructured":"Drummer C et al (2021) Trained immunity and reactivity of macrophages and endothelial cells. Arterioscler Thromb Vasc Biol 41(3):1032\u20131046","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7293","key":"361_CR31","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","volume":"464","author":"P Duewell","year":"2010","unstructured":"Duewell P et al (2010) NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464(7293):1357\u20131361","journal-title":"Nature"},{"issue":"5","key":"361_CR32","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.4049\/jimmunol.0903526","volume":"184","author":"N Dufton","year":"2010","unstructured":"Dufton N et al (2010) Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation. J Immunol 184(5):2611\u20132619","journal-title":"J Immunol"},{"issue":"8","key":"361_CR33","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1096\/fj.201500155R","volume":"30","author":"TK Elajami","year":"2016","unstructured":"Elajami TK et al (2016) Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling. FASEB J 30(8):2792\u20132801","journal-title":"FASEB J"},{"issue":"2","key":"361_CR34","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/cvr\/cvaf258","volume":"122","author":"BR Evans","year":"2026","unstructured":"Evans BR et al (2026) ChemR23 prevents phenotypic switching of vascular smooth muscle cells into macrophage-like foam cells in atherosclerosis. Cardiovasc Res 122(2):195\u2013213","journal-title":"Cardiovasc Res"},{"issue":"1","key":"361_CR35","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/imr.13278","volume":"319","author":"G Fredman","year":"2023","unstructured":"Fredman G, Khan S (2023) Specialized pro-resolving mediators enhance the clearance of dead cells. Immunol Rev 319(1):151\u2013157","journal-title":"Immunol Rev"},{"issue":"11","key":"361_CR36","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/s41569-023-00984-x","volume":"21","author":"G Fredman","year":"2024","unstructured":"Fredman G, Serhan CN (2024) Specialized pro-resolving mediators in vascular inflammation and atherosclerotic cardiovascular disease. Nat Rev Cardiol 21(11):808\u2013823","journal-title":"Nat Rev Cardiol"},{"key":"361_CR37","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.mam.2017.02.003","volume":"58","author":"G Fredman","year":"2017","unstructured":"Fredman G, Spite M (2017) Specialized pro-resolving mediators in cardiovascular diseases. Mol Asp Med 58:65\u201371","journal-title":"Mol Asp Med"},{"issue":"40","key":"361_CR38","doi-asserted-by":"crossref","first-page":"14530","DOI":"10.1073\/pnas.1410851111","volume":"111","author":"G Fredman","year":"2014","unstructured":"Fredman G et al (2014) Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B4 synthesis by inhibiting a calcium-activated kinase pathway. Proc Natl Acad Sci USA 111(40):14530\u201314535","journal-title":"Proc Natl Acad Sci USA"},{"issue":"275","key":"361_CR39","doi-asserted-by":"crossref","first-page":"275ra20","DOI":"10.1126\/scitranslmed.aaa1065","volume":"7","author":"G Fredman","year":"2015","unstructured":"Fredman G et al (2015) Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice. Sci Transl Med 7(275):275ra20","journal-title":"Sci Transl Med"},{"issue":"1","key":"361_CR40","doi-asserted-by":"crossref","first-page":"12859","DOI":"10.1038\/ncomms12859","volume":"7","author":"G Fredman","year":"2016","unstructured":"Fredman G et al (2016) An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques. Nat Commun 7(1):12859","journal-title":"Nat Commun"},{"issue":"13","key":"361_CR41","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1161\/CIRCULATIONAHA.108.806158","volume":"119","author":"EL Gautier","year":"2009","unstructured":"Gautier EL et al (2009) Macrophage apoptosis exerts divergent effects on atherogenesis as a function of lesion stage. Circulation 119(13):1795\u20131804","journal-title":"Circulation"},{"issue":"2","key":"361_CR42","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41418-019-0370-1","volume":"27","author":"BD Gerlach","year":"2020","unstructured":"Gerlach BD et al (2020) Resolvin D1 promotes the targeting and clearance of necroptotic cells. Cell Death Differ 27(2):525\u2013539","journal-title":"Cell Death Differ"},{"issue":"4","key":"361_CR43","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","volume":"118","author":"MA Gimbrone Jr","year":"2016","unstructured":"Gimbrone MA Jr, Garc\u00eda-Carde\u00f1a G (2016) Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ Res 118(4):620\u2013636","journal-title":"Circ Res"},{"issue":"28","key":"361_CR44","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1093\/eurheartj\/ehaf1091","volume":"47","author":"I Goncalves","year":"2026","unstructured":"Goncalves I et al (2026) Spatial transcriptomics reveals a key role of fibroblast-like vascular smooth muscle cells in human atherosclerotic cell crosstalk and stability. Eur Heart J 47(28):3711\u20133732","journal-title":"Eur Heart J"},{"issue":"6","key":"361_CR45","doi-asserted-by":"crossref","first-page":"oeaf157","DOI":"10.1093\/ehjopen\/oeaf157","volume":"5","author":"GV Halade","year":"2025","unstructured":"Halade GV, B\u00e4ck M, Kain V (2025) Inflammation-resolution signalling in cardiac repair, remodelling, and heart failure. Eur Heart J Open 5(6):oeaf157","journal-title":"Eur Heart J Open"},{"issue":"6885","key":"361_CR46","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/417182a","volume":"417","author":"R Hanayama","year":"2002","unstructured":"Hanayama R et al (2002) Identification of a factor that links apoptotic cells to phagocytes. Nature 417(6885):182\u2013187","journal-title":"Nature"},{"issue":"3","key":"361_CR47","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/CIRCRESAHA.111.253377","volume":"110","author":"RN Hanna","year":"2012","unstructured":"Hanna RN et al (2012) NR4A1 (Nur77) deletion polarizes macrophages toward an inflammatory phenotype and increases atherosclerosis. Circ Res 110(3):416\u2013427","journal-title":"Circ Res"},{"issue":"5","key":"361_CR48","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/ATVBAHA.115.305324","volume":"35","author":"H Hasturk","year":"2015","unstructured":"Hasturk H et al (2015) Resolvin E1 (RvE1) attenuates atherosclerotic plaque formation in diet and inflammation-induced atherogenesis. Arterioscler Thromb Vasc Biol 35(5):1123\u20131133","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"361_CR49","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.2353\/ajpath.2010.091082","volume":"177","author":"KJ Ho","year":"2010","unstructured":"Ho KJ et al (2010) Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis. Am J Pathol 177(4):2116\u20132123","journal-title":"Am J Pathol"},{"issue":"3","key":"361_CR50","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1161\/ATVBAHA.120.315758","volume":"41","author":"Z Hosseini","year":"2021","unstructured":"Hosseini Z et al (2021) Resolvin D1 enhances necroptotic cell clearance through promoting macrophage fatty acid oxidation and oxidative phosphorylation. Arterioscler Thromb Vasc Biol 41(3):1062\u20131075","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"361_CR51","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nm0410-396","volume":"16","author":"GS Hotamisligil","year":"2010","unstructured":"Hotamisligil GS (2010) Endoplasmic reticulum stress and atherosclerosis. Nat Med 16(4):396\u2013399","journal-title":"Nat Med"},{"issue":"7","key":"361_CR52","doi-asserted-by":"crossref","first-page":"e134796","DOI":"10.1172\/jci.insight.134796","volume":"5","author":"T Josefs","year":"2020","unstructured":"Josefs T et al (2020) Neutrophil extracellular traps promote macrophage inflammation and impair atherosclerosis resolution in diabetic mice. JCI Insight 5(7):e134796","journal-title":"JCI Insight"},{"issue":"5","key":"361_CR53","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.1021\/acsnano.6b01114","volume":"10","author":"N Kamaly","year":"2016","unstructured":"Kamaly N et al (2016) Targeted Interleukin-10 nanotherapeutics developed with a microfluidic chip enhance resolution of inflammation in advanced atherosclerosis. ACS Nano 10(5):5280\u20135292","journal-title":"ACS Nano"},{"issue":"7","key":"361_CR54","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1600224","volume":"2","author":"D Karunakaran","year":"2016","unstructured":"Karunakaran D et al (2016) Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis. Sci Adv 2(7):e1600224","journal-title":"Sci Adv"},{"issue":"4","key":"361_CR55","doi-asserted-by":"crossref","first-page":"E550","DOI":"10.1073\/pnas.1613063114","volume":"114","author":"RS Khambata","year":"2017","unstructured":"Khambata RS et al (2017) Antiinflammatory actions of inorganic nitrate stabilize the atherosclerotic plaque. Proc Natl Acad Sci 114(4):E550\u2013E559","journal-title":"Proc Natl Acad Sci"},{"issue":"7614","key":"361_CR56","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/nature18935","volume":"536","author":"Y Kojima","year":"2016","unstructured":"Kojima Y et al (2016) CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis. Nature 536(7614):86\u201390","journal-title":"Nature"},{"issue":"16","key":"361_CR57","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1161\/CIRCULATIONAHA.117.032801","volume":"138","author":"A Laguna-Fernandez","year":"2018","unstructured":"Laguna-Fernandez A et al (2018) ERV1\/ChemR23 signaling protects against atherosclerosis by modifying oxidized low-density lipoprotein uptake and phagocytosis in macrophages. Circulation 138(16):1693\u20131705","journal-title":"Circulation"},{"issue":"7","key":"361_CR58","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/89759","volume":"2","author":"BD Levy","year":"2001","unstructured":"Levy BD et al (2001) Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol 2(7):612\u2013619","journal-title":"Nat Immunol"},{"issue":"6917","key":"361_CR59","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","volume":"420","author":"P Libby","year":"2002","unstructured":"Libby P (2002) Inflammation in atherosclerosis. Nature 420(6917):868\u2013874","journal-title":"Nature"},{"issue":"6","key":"361_CR60","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202302336RR","volume":"38","author":"M Lipscomb","year":"2024","unstructured":"Lipscomb M et al (2024) Resolvin D2 limits atherosclerosis progression via myeloid cell-GPR18. FASEB J 38(6):e23555","journal-title":"FASEB J"},{"key":"361_CR61","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2025.107527","volume":"160","author":"M Lipscomb","year":"2025","unstructured":"Lipscomb M et al (2025) Resolvin D2 limits senescent cell accumulation in atherosclerotic plaques. Vasc Pharmacol 160:107527","journal-title":"Vasc Pharmacol"},{"issue":"1","key":"361_CR62","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1161\/01.ATV.0000148548.47755.22","volume":"25","author":"J Liu","year":"2005","unstructured":"Liu J et al (2005) Reduced macrophage apoptosis is associated with accelerated atherosclerosis in low-density lipoprotein receptor-null mice. Arterioscler Thromb Vasc Biol 25(1):174\u2013179","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"361_CR63","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1161\/CIRCRESAHA.123.323223","volume":"134","author":"JJ Lv","year":"2024","unstructured":"Lv JJ et al (2024) CD147 sparks atherosclerosis by driving M1 phenotype and impairing efferocytosis. Circ Res 134(2):165\u2013185","journal-title":"Circ Res"},{"issue":"3","key":"361_CR64","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1172\/JCI85113","volume":"127","author":"C Mauri","year":"2017","unstructured":"Mauri C, Menon M (2017) Human regulatory B cells in health and disease: therapeutic potential. J Clin Invest 127(3):772\u2013779","journal-title":"J Clin Invest"},{"issue":"10","key":"361_CR65","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1096\/fj.08-112201","volume":"22","author":"AJ Merched","year":"2008","unstructured":"Merched AJ et al (2008) Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. FASEB J 22(10):3595\u20133606","journal-title":"FASEB J"},{"issue":"15","key":"361_CR66","doi-asserted-by":"crossref","first-page":"5634","DOI":"10.1073\/pnas.0401060101","volume":"101","author":"C Monaco","year":"2004","unstructured":"Monaco C et al (2004) Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis. Proc Natl Acad Sci USA 101(15):5634\u20135639","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"361_CR67","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1161\/CIRCRESAHA.108.187534","volume":"103","author":"D Morrow","year":"2008","unstructured":"Morrow D et al (2008) Notch and vascular smooth muscle cell phenotype. Circ Res 103(12):1370\u20131382","journal-title":"Circ Res"},{"issue":"1","key":"361_CR68","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/ATVBAHA.121.316854","volume":"42","author":"PA Mueller","year":"2022","unstructured":"Mueller PA et al (2022) Macrophage LRP1 (low-density lipoprotein receptor-related protein 1) is required for the effect of CD47 blockade on efferocytosis and atherogenesis-brief report. Arterioscler Thromb Vasc Biol 42(1):e1\u2013e9","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"47","key":"361_CR69","doi-asserted-by":"crossref","first-page":"29411","DOI":"10.1074\/jbc.272.47.29411","volume":"272","author":"T Nakano","year":"1997","unstructured":"Nakano T et al (1997) Cell adhesion to phosphatidylserine mediated by a product of growth arrest-specific gene 6. J Biol Chem 272(47):29411\u201329414","journal-title":"J Biol Chem"},{"issue":"2","key":"361_CR70","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1172\/JCI116670","volume":"92","author":"KD O\u2019Brien","year":"1993","unstructured":"O\u2019Brien KD et al (1993) Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest 92(2):945\u2013951","journal-title":"J Clin Invest"},{"issue":"1","key":"361_CR71","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13293-024-00652-w","volume":"15","author":"DE Paparini","year":"2024","unstructured":"Paparini DE et al (2024) Sex-specific phenotypical, functional and metabolic profiles of human term placenta macrophages. Biol Sex Differ 15(1):80","journal-title":"Biol Sex Differ"},{"issue":"1","key":"361_CR72","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nri2470","volume":"9","author":"M Perretti","year":"2009","unstructured":"Perretti M, D\u2019Acquisto F (2009) Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat Rev Immunol 9(1):62\u201370","journal-title":"Nat Rev Immunol"},{"key":"361_CR73","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2022.101669","volume":"65","author":"M Perretti","year":"2023","unstructured":"Perretti M, Subramanian M (2023) Resolution pharmacology \u2013 a fresh approach to the clinical management of human inflammatory diseases. Semin Immunol 65:101669","journal-title":"Semin Immunol"},{"key":"361_CR74","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123315","volume":"361","author":"N Pervaiz","year":"2025","unstructured":"Pervaiz N et al (2025) Smooth muscle cell-specific CD47 deletion suppresses atherosclerosis. Life Sci 361:123315","journal-title":"Life Sci"},{"issue":"22","key":"361_CR75","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1111\/bph.13707","volume":"174","author":"MH Petri","year":"2017","unstructured":"Petri MH et al (2017) Aspirin-triggered lipoxin A4 inhibits atherosclerosis progression in apolipoprotein E(\u2212\/\u2212) mice. Br J Pharmacol 174(22):4043\u20134054","journal-title":"Br J Pharmacol"},{"key":"361_CR76","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1093\/eurheartj\/ehag117","volume":"47","author":"KHM Prange","year":"2026","unstructured":"Prange KHM et al (2026) Carotid plaque macrophage burden and inflammatory lipid-associated macrophage markers predict secondary major adverse cardiovascular events after endarterectomy. Eur Heart J 47:3821\u20133836","journal-title":"Eur Heart J"},{"issue":"4","key":"361_CR77","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.immuni.2018.07.015","volume":"49","author":"JD Proto","year":"2018","unstructured":"Proto JD et al (2018) Regulatory T cells promote macrophage efferocytosis during inflammation resolution. Immunity 49(4):666\u2013677.e6","journal-title":"Immunity"},{"issue":"19","key":"361_CR78","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1111\/bph.15919","volume":"179","author":"CX Qin","year":"2022","unstructured":"Qin CX et al (2022) Formylpeptide receptor 2: nomenclature, structure, signalling and translational perspectives: IUPHAR review 35. Br J Pharmacol 179(19):4617\u20134639","journal-title":"Br J Pharmacol"},{"issue":"5985","key":"361_CR79","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1126\/science.1189862","volume":"328","author":"KJ Rayner","year":"2010","unstructured":"Rayner KJ et al (2010) MiR-33 contributes to the regulation of cholesterol homeostasis. Science 328(5985):1570\u20131573","journal-title":"Science"},{"issue":"12","key":"361_CR80","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM et al (2017) Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med 377(12):1119\u20131131","journal-title":"N Engl J Med"},{"issue":"12","key":"361_CR81","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41569-023-00894-y","volume":"20","author":"NP Riksen","year":"2023","unstructured":"Riksen NP et al (2023) Trained immunity in atherosclerotic cardiovascular disease. Nat Rev Cardiol 20(12):799\u2013811","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"361_CR82","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1096\/fj.201902126R","volume":"34","author":"N Rymut","year":"2020","unstructured":"Rymut N et al (2020) Resolvin D1 promotes efferocytosis in aging by limiting senescent cell-induced MerTK cleavage. FASEB J 34(1):597\u2013609","journal-title":"FASEB J"},{"issue":"7","key":"361_CR83","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.4049\/jimmunol.2100284","volume":"207","author":"S Sadhu","year":"2021","unstructured":"Sadhu S et al (2021) Radiation-induced macrophage senescence impairs resolution programs and drives cardiovascular inflammation. J Immunol 207(7):1812\u20131823","journal-title":"J Immunol"},{"issue":"15","key":"361_CR84","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.016113","volume":"9","author":"MS Schaller","year":"2020","unstructured":"Schaller MS et al (2020) Treatment with a marine oil supplement alters lipid mediators and leukocyte phenotype in healthy patients and those with peripheral artery disease. J Am Heart Assoc 9(15):e016113","journal-title":"J Am Heart Assoc"},{"issue":"Suppl 1","key":"361_CR85","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1538-7836.2009.03396.x","volume":"7","author":"CN Serhan","year":"2009","unstructured":"Serhan CN (2009) Systems approach to inflammation resolution: identification of novel anti-inflammatory and pro-resolving mediators. J Thromb Haemost 7(Suppl 1):44\u201348","journal-title":"J Thromb Haemost"},{"issue":"12","key":"361_CR86","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/ni1276","volume":"6","author":"CN Serhan","year":"2005","unstructured":"Serhan CN, Savill J (2005) Resolution of inflammation: the beginning programs the end. Nat Immunol 6(12):1191\u20131197","journal-title":"Nat Immunol"},{"issue":"12","key":"361_CR87","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1161\/ATVBAHA.112.300471","volume":"32","author":"N Sharma","year":"2012","unstructured":"Sharma N et al (2012) Myeloid Kr\u00fcppel-like factor 4 deficiency augments atherogenesis in ApoE\u2212\/\u2212 mice\u2014brief report. Arterioscler Thromb Vasc Biol 32(12):2836\u20132838","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"361_CR88","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2025.108917","volume":"274","author":"S Shetty","year":"2025","unstructured":"Shetty S, Subramanian M (2025) Neutrophil extracellular traps (NETs) as drivers of atherosclerosis: pathogenic mechanisms and therapeutic opportunities. Pharmacol Ther 274:108917","journal-title":"Pharmacol Ther"},{"issue":"1","key":"361_CR89","doi-asserted-by":"crossref","first-page":"6135","DOI":"10.1038\/s41467-020-19664-2","volume":"11","author":"V Simion","year":"2020","unstructured":"Simion V et al (2020) A macrophage-specific lncRNA regulates apoptosis and atherosclerosis by tethering HuR in the nucleus. Nat Commun 11(1):6135","journal-title":"Nat Commun"},{"issue":"12","key":"361_CR90","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1161\/CIRCRESAHA.125.326839","volume":"137","author":"A Singhal","year":"2025","unstructured":"Singhal A et al (2025) TRIB3 links endoplasmic reticulum stress to impaired efferocytosis in atherosclerosis. Circ Res 137(12):1422\u20131442","journal-title":"Circ Res"},{"issue":"1","key":"361_CR91","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1172\/JCI64617","volume":"123","author":"M Subramanian","year":"2013","unstructured":"Subramanian M et al (2013) Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs. J Clin Invest 123(1):179\u2013188","journal-title":"J Clin Invest"},{"key":"361_CR92","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fimmu.2016.00160","volume":"7","author":"MA Sugimoto","year":"2016","unstructured":"Sugimoto MA et al (2016) Resolution of inflammation: what controls its onset? Front Immunol 7:160","journal-title":"Front Immunol"},{"issue":"4","key":"361_CR93","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s44161-025-00628-y","volume":"4","author":"K Sukhavasi","year":"2025","unstructured":"Sukhavasi K et al (2025) Single-cell RNA sequencing reveals sex differences in the subcellular composition and associated gene-regulatory network activity of human carotid plaques. Nat Cardiovasc Res 4(4):412\u2013432","journal-title":"Nat Cardiovasc Res"},{"issue":"9","key":"361_CR94","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/s42255-024-01115-7","volume":"6","author":"SR Sukka","year":"2024","unstructured":"Sukka SR et al (2024) Efferocytosis drives a tryptophan metabolism pathway in macrophages to promote tissue resolution. Nat Metab 6(9):1736\u20131755","journal-title":"Nat Metab"},{"issue":"18","key":"361_CR95","doi-asserted-by":"crossref","first-page":"11896","DOI":"10.1073\/pnas.182199799","volume":"99","author":"RK Tangirala","year":"2002","unstructured":"Tangirala RK et al (2002) Identification of macrophage liver X receptors as inhibitors of atherosclerosis. Proc Natl Acad Sci USA 99(18):11896\u201311901","journal-title":"Proc Natl Acad Sci USA"},{"issue":"553","key":"361_CR96","doi-asserted-by":"crossref","first-page":"eaay1063","DOI":"10.1126\/scitranslmed.aay1063","volume":"12","author":"W Tao","year":"2020","unstructured":"Tao W et al (2020) siRNA nanoparticles targeting CaMKII\u03b3 in lesional macrophages improve atherosclerotic plaque stability in mice. Sci Transl Med 12(553):eaay1063","journal-title":"Sci Transl Med"},{"issue":"22","key":"361_CR97","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/eurheartj\/ehv759","volume":"37","author":"D Tousoulis","year":"2016","unstructured":"Tousoulis D et al (2016) Inflammatory cytokines in atherosclerosis: current therapeutic approaches. Eur Heart J 37(22):1723\u20131732","journal-title":"Eur Heart J"},{"issue":"1","key":"361_CR98","doi-asserted-by":"crossref","first-page":"8255","DOI":"10.1038\/s41467-025-63202-x","volume":"16","author":"K Traeuble","year":"2025","unstructured":"Traeuble K et al (2025) Integrated single-cell atlas of human atherosclerotic plaques. Nat Commun 16(1):8255","journal-title":"Nat Commun"},{"issue":"13","key":"361_CR99","first-page":"2537","volume":"117","author":"J Vallejo","year":"2021","unstructured":"Vallejo J et al (2021) Heterogeneity of immune cells in human atherosclerosis revealed by scRNA-Seq. Cardiovasc Res 117(13):2537\u20132543","journal-title":"Cardiovasc Res"},{"issue":"4","key":"361_CR100","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1161\/ATVBAHA.119.312386","volume":"39","author":"EPC van der Vorst","year":"2019","unstructured":"van der Vorst EPC et al (2019) Hematopoietic ChemR23 (chemerin receptor 23) fuels atherosclerosis by sustaining an M1 macrophage-phenotype and guidance of plasmacytoid dendritic cells to murine lesions\u2014brief report. Arterioscler Thromb Vasc Biol 39(4):685\u2013693","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"361_CR101","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1161\/CIRCRESAHA.116.309492","volume":"119","author":"JR Viola","year":"2016","unstructured":"Viola JR et al (2016) Resolving lipid mediators maresin 1 and resolvin D2 prevent atheroprogression in mice. Circ Res 119(9):1030\u20131038","journal-title":"Circ Res"},{"issue":"1","key":"361_CR102","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/s41467-024-44868-1","volume":"15","author":"ME Walker","year":"2024","unstructured":"Walker ME et al (2024) Resolvin T4 enhances macrophage cholesterol efflux to reduce vascular disease. Nat Commun 15(1):975","journal-title":"Nat Commun"},{"issue":"6","key":"361_CR103","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.3390\/ijms26062667","volume":"26","author":"X Wang","year":"2025","unstructured":"Wang X, Liu R, Liu D (2025) The role of the MAPK signaling pathway in cardiovascular disease: pathophysiological mechanisms and clinical therapy. Int J Mol Sci 26(6):2667","journal-title":"Int J Mol Sci"},{"issue":"6245","key":"361_CR104","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1126\/science.aaa8064","volume":"349","author":"A Warnatsch","year":"2015","unstructured":"Warnatsch A et al (2015) Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis. Science 349(6245):316\u2013320","journal-title":"Science"},{"issue":"1","key":"361_CR105","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ymthe.2019.09.008","volume":"28","author":"Y Xu","year":"2020","unstructured":"Xu Y et al (2020) Macrophage miR-34a is a key regulator of cholesterol efflux and atherosclerosis. Mol Ther 28(1):202\u2013216","journal-title":"Mol Ther"},{"issue":"4","key":"361_CR106","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/ATVBAHA.109.202051","volume":"30","author":"PG Yancey","year":"2010","unstructured":"Yancey PG et al (2010) Macrophage LRP-1 controls plaque cellularity by regulating efferocytosis and Akt activation. Arterioscler Thromb Vasc Biol 30(4):787\u2013795","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"361_CR107","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41419-019-1409-4","volume":"10","author":"ZM Ye","year":"2019","unstructured":"Ye ZM et al (2019) LncRNA MIAT sponges miR-149-5p to inhibit efferocytosis in advanced atherosclerosis through CD47 upregulation. Cell Death Dis 10(2):138","journal-title":"Cell Death Dis"},{"issue":"3","key":"361_CR108","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.cmet.2020.01.001","volume":"31","author":"A Yurdagul Jr","year":"2020","unstructured":"Yurdagul A Jr et al (2020) Macrophage metabolism of apoptotic cell-derived arginine promotes continual efferocytosis and resolution of injury. Cell Metab 31(3):518\u2013533.e10","journal-title":"Cell Metab"},{"issue":"3","key":"361_CR109","first-page":"e144","volume":"41","author":"A Yurdagul Jr","year":"2021","unstructured":"Yurdagul A Jr et al (2021) ODC (ornithine decarboxylase)-dependent putrescine synthesis maintains MerTK (MER tyrosine-protein kinase) expression to drive resolution. Arterioscler Thromb Vasc Biol 41(3):e144\u2013e159","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"361_CR110","volume":"161","author":"S Zhang","year":"2020","unstructured":"Zhang S et al (2020) Biased allosteric modulation of formyl peptide receptor 2 leads to distinct receptor conformational states for pro- and anti-inflammatory signaling. Pharmacol Res 161:105117","journal-title":"Pharmacol Res"}],"container-title":["Current Topics in Microbiology and Immunology"],"original-title":[],"link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/82_2026_361","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:33:34Z","timestamp":1790750014000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/82_2026_361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":110,"URL":"https:\/\/doi.org\/10.1007\/82_2026_361","relation":{},"ISSN":["0070-217X","2196-9965"],"issn-type":[{"value":"0070-217X","type":"print"},{"value":"2196-9965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"1 October 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"None","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The author(s) declares that this manuscript does not include primary research with human participants.The author(s) declares that this manuscript does not include primary studies involving animals.","order":2,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}